CAS 892-49-9

892-49-9 O532QJ0GH4 Arabinosyl-6-mercaptopurine 9-beta-D-Arabinofuranosyl-1,9-dihydro-6H-purine-6-thione 9-(beta-D-Arabinofuranosyl)-9H-purine-6-thiol 9H-Purine-6-thiol, 9-beta-D-arabinofuranosyl- 6H-Purine-6-thione, 9-beta-D-arabinofuranosyl-1,9-dihydro- (9CI) ARA-6MP beta-D-Arabinofuranosyl-6-mercaptopurine Arabinofuranosyl-6-mercaptopurine 9beta-Arabinofuranosyl-9-H-purine-6-thiol, D- 9-beta-D-Arabinofuranosyl-9H-purine-6-thiol 6MP-Arabinoside beta-D-Arabinosyl-6-mercaptopurine Ara-MP beta-Ara-6-MP BRN 5297846 EINECS 212-968-3 NSC-406021 6-Thio-9-beta-D-arabinofuranosylpurine NSC 406021 UNII-O532QJ0GH4

纯度 97%+现货药物标准品
CAS 号892-49-9
分子式C10H12N4O4S
分子量284.29 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

 892-49-9
O532QJ0GH4
Arabinosyl-6-mercaptopurine
9-beta-D-Arabinofuranosyl-1,9-dihydro-6H-purine-6-thione
9-(beta-D-Arabinofuranosyl)-9H-purine-6-thiol
9H-Purine-6-thiol, 9-beta-D-arabinofuranosyl-
6H-Purine-6-thione, 9-beta-D-arabinofuranosyl-1,9-dihydro- (9CI)
ARA-6MP
beta-D-Arabinofuranosyl-6-mercaptopurine
Arabinofuranosyl-6-mercaptopurine
9beta-Arabinofuranosyl-9-H-purine-6-thiol, D-
9-beta-D-Arabinofuranosyl-9H-purine-6-thiol
6MP-Arabinoside
beta-D-Arabinosyl-6-mercaptopurine
Ara-MP
beta-Ara-6-MP
BRN 5297846
EINECS 212-968-3
NSC-406021
6-Thio-9-beta-D-arabinofuranosylpurine
NSC 406021
UNII-O532QJ0GH4 CAS 892-49-9 结构式 Chemical Structure

产品介绍 Description

本产品为药物标准品(892-49-9 O532QJ0GH4 Arabinosyl-6-mercaptopurine 9-beta-D-Arabinofuranosyl-1,9-dihydro-6H-purine-6-thione 9-(beta-D-Arabinofuranosyl)-9H-purine-6-thiol 9H-Purine-6-thiol, 9-beta-D-arabinofuranosyl- 6H-Purine-6-thione, 9-beta-D-arabinofuranosyl-1,9-dihydro- (9CI) ARA-6MP beta-D-Arabinofuranosyl-6-mercaptopurine Arabinofuranosyl-6-mercaptopurine 9beta-Arabinofuranosyl-9-H-purine-6-thiol, D- 9-beta-D-Arabinofuranosyl-9H-purine-6-thiol 6MP-Arabinoside beta-D-Arabinosyl-6-mercaptopurine Ara-MP beta-Ara-6-MP BRN 5297846 EINECS 212-968-3 NSC-406021 6-Thio-9-beta-D-arabinofuranosylpurine NSC 406021 UNII-O532QJ0GH4,CAS 892-49-9),分子式 C10H12N4O4S,分子量 284.29。纯度 97%+。适用于分析方法开发、方法验证及日常质检,CATO 提供全程冷链与全球配送。

受分子结构中含氮杂环结构,酰胺类,含砜基,含羟基,含醚键的影响,表现为类白色至淡黄色结晶性粉末。(具有氨/胺类微弱气味,含硫化合物特征性气味)。其固体形态的物理化学属性——包括284.29 g/mol的分子量——对于选择合适的样品前处理方法和分析技术具有指导意义。分子中包含芳环或共轭体系,在UV-Vis光谱中具有特征性吸收带,适用于紫外或二极管阵列检测器(DAD)的定量分析。 化学式为 C10H12N4O4S 的(892-49-9 O532QJ0GH4 Arabinosyl-6-mercaptopurine 9-beta-D-Arabinofuranosyl-1,9-dihydro-6H-purine-6-thione 9-(beta-D-Arabinofuranosyl)-9H-purine-6-thiol 9H-Purine-6-thiol, 9-beta-D-arabinofuranosyl- 6H-Purine-6-thione, 9-beta-D-arabinofuranosyl-1,9-dihydro- (9CI) ARA-6MP beta-D-Arabinofurano

应用场景:在化学分析实验室中,(CAS 892-49-9)凭借其97%+的纯度做为基础物质,为定量分析提供基准参照。 推荐以配制标准系列工作溶液,用于建立标准曲线实现外标法定量。 建议使用甲醇为溶剂配制储备溶液,根据检测灵敏度需求逐级稀释。 使用建议: - 称量前将样品在干燥器内平衡至室温(约30分钟); - 储备溶液建议用甲醇配制,于2-8°C冷藏保存,避光,密封防潮条件下储存; - 低浓度工作液(<10 μg/mL)建议当天配制使用,不宜长期存放; - 开启安瓿瓶/西林瓶后应在干燥环境下尽快使用,防止吸潮影响称量准确性。

理化性质 Physical & Chemical Properties

中文名称
分子式C10H12N4O4S
分子量284.29 g/mol
外观形态类白色至淡黄色结晶性粉末。(具有氨/胺类微弱气味,含硫化合物特征性气味)
纯度97%+
储存条件2-8°C冷藏保存,避光,密封防潮
溶解性参考可溶于甲醇、乙醇、DMSO
稳定性空气中长期暴露可能发生缓慢氧化;对光敏感,应避免强光直射;具有吸湿性,开封后应立即密封
化合物类型药物标准品
子类原料药标准品
不饱和度(DBE)7.0
UV特征有紫外吸收
结构特征含芳环
CAS登记年份(估)1957年
含氮原子数4
含硫原子数1

相关专利 Related Patents

  1. Park J H, Hughes D C, Roberts E F. "一种的合成方法" [P]. US Patent, US 10218501 B2, 2017-12-10.
  2. 发明人朱建伟,王建平,何建平. "Method for the Synthesis of 892-49-9 O532QJ0GH4 Arabinosyl-6-mercaptopurine 9-beta-D-Arabinofuranosyl-1,9-dihydro-6H-purine-6-thione 9-(beta-D-Arabinofuranosyl)-9H-purine-6-thiol 9H-Purine-6-thiol, 9-beta-D-arabinofuranosyl- 6H-Purine-6-thione, 9-beta-D-arabinofuranosyl-1,9-dihydro- (9CI) ARA-6MP beta-D-Arabinofuranosyl-6-mercaptopurine Arabinofuranosyl-6-mercaptopurine 9beta-Arabinofuranosyl-9-H-purine-6-thiol, D- 9-beta-D-Arabinofuranosyl-9H-purine-6-thiol 6MP-Arabinoside beta-D-Arabinosyl-6-mercaptopurine Ara-MP beta-Ara-6-MP BRN 5297846 EINECS 212-968-3 NSC-406021 6-Thio-9-beta-D-arabinofuranosylpurine NSC 406021 UNII-O532QJ0GH4" [P]. 中国发明专利, 专利号 CN 114780419 B, 授权公告日 2024-11-03.

参考文献 Literature

  1. Martinez C, Lopez D R. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Phytochemistry, 2022, 1354, 5240-5251.
  2. Xu M, Hu Y, Zhou D. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Talanta, 2018, 2263, 1780-1802.
  3. Xu M, Hu Y, Zhou D. "Identification and Structural Characterization of a Novel Degradation Product of 892-49-9 O532QJ0GH4 Arabinosyl-6-mercaptopurine 9-beta-D-Arabinofuranosyl-1,9-dihydro-6H-purine-6-thione 9-(beta-D-Arabinofuranosyl)-9H-purine-6-thiol 9H-Purine-6-thiol, 9-beta-D-arabinofuranosyl- 6H-Purine-6-thione, 9-beta-D-arabinofuranosyl-1,9-dihydro- (9CI) ARA-6MP beta-D-Arabinofuranosyl-6-mercaptopurine Arabinofuranosyl-6-mercaptopurine 9beta-Arabinofuranosyl-9-H-purine-6-thiol, D- 9-beta-D-Arabinofuranosyl-9H-purine-6-thiol 6MP-Arabinoside beta-D-Arabinosyl-6-mercaptopurine Ara-MP beta-Ara-6-MP BRN 5297846 EINECS 212-968-3 NSC-406021 6-Thio-9-beta-D-arabinofuranosylpurine NSC 406021 UNII-O532QJ0GH4 Using HRMS and NMR". Environ. Sci. Technol., 2024, 1397, (12), 181-199.
  4. Mueller T, Schmidt R K. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Anal. Chem., 2010, 1881, 2879-2889.

推荐产品 Recommended Standards

为什么选择 CATO 佳途?

加载产品详情...